ECRIN – Needed in European Science A

Topic explanation: Modern trends of development in the fi eld of applied science show that the investigator initiated clinical trials are very reliable way of developing and achieving a better quality of health services in all aspects of the organization of health systems. Presenting the topic position to scientifi c/professional public: ECRIN scientifi c partner for Serbia is Serbian Medical Society. The three medical areas supported in this project (rare diseases, medical devices, and nutrition) will serve as pilots for other biomedical research fi elds. For Serbia, the advantages of participating in ECRIN are: a structuring eff ect on the national clinical research community and infrastructure ; a connection to the European infrastructure; allowing projects initiated in Serbian Medical Institutions via SMS to be run throughout the Europe and allowing projects initiated in any European country to be run in Serbia. Conclusion: Permanent cooperation through ECRIN ERIC SMS is a position that enables younger doctors of Serbia the development of science teams in Europe and the world. Time will show whether we will succeed through ECRIN to apply medical knowledge of XXI century.


Topic explanation
Sponsored (commercial) clinical studies have supported and understandable attention of pharmaceutical companies, which is a direct zone of interest.Modern trends of development in the fi eld of applied science show that the investigator initiated clinical trials are very reliable way of developing and achieving a better quality of health services in all aspects of the organization of health systems.However, as in everything that occurs spontaneously, budget is an obstacle.Europian Clinical Research Infrastructure Network (ECRIN) -European network of academic projects is originated from the need to researchers, primarily from Europe, enable collaboration, realization of projects, with logistical and fi nancial support.Th en it turned into a planetary support with connection of other continents in presenting and improving the topic position to scientifi c/ professional public [1].clinical research of international type.Interesting and promising response we received from Prof. Jacques Demotes from France.He clearly showed the objectives and methodology of a future ECRIN.We completely believed and immediately reported our Serbia to cooperate as ECRIN partners.Th en the time ran and in 2007 started realization.
Th e best partner that satisfi es set goals turned out to be Serbian Medical Society (SMS) [2].Features/advantages of SMS are: rights to membership in SMS have all the doctors Serbia; all medical institutions cooperate with each other through SMS; iIt is possible to make high-quality monitoring and coordination of academic studies; possible direct communication with all researchers in Serbia; bypasses the impact of management structure (institutional management) in forming research teams; enables the two-way scientifi c exchange -Serbia -Europe and vice versa.
For Serbia, the advantages of participating in ECRIN are: a structuring eff ect on the national clinical research community and infrastructure; a connection to the European infrastructure, allowing projects initiated in Serbian Medical Institutions via SMS to be run throughout the Europe and allowing projects initiated in any European country to be run in Serbia.
Common benefi t for all involved in the ECRIN: it is possible to supplement the resources of other countries: human resources, laboratories, patients, logistical support; it is possible to be supported in the development of protocols; analysis of the results obtained on a large number of patients.
When a doctor starts involvement in research quickly realize that there are plenty of obstacles.First appears the lack of an organizational nature.Th en, as for all the advances that occur spontaneously, it requires a budget.Th is ECRIN European team has proven that people who carry the progress are exactly the same regardless of the state or other affi liation.Th e cosmopolitan European team grew through the project of integration in the fi eld of applied science as a team, and individually.Each subsequent teleconference became the most important activity which we rejoiced.Naturally, without passion we wouldn't have withstood the pace.We learned and gained insight into how we are positioned in relation to other European countries and over time the continents.
SMS support came from the Ministry of Science and Health of Serbia, and the largest of doctors from all levels in our country.We thought that we are lagging behind in knowledge and constructive ideas.Time has shown that we are lagging behind the budget and one ordinary human handshake of individual authority.But all this is less important with regard to the benefi t of doctors attending a symposium WHCP, listen ECRIN lectures, participate in projects.
Th e three medical areas supported in this project (rare diseases, medical devices, and nutrition) will serve as pilots for other biomedical research fi elds [10] By creating a single area for clinical research in Europe, this structure will contribute to the implementation of the Europe fl agship initiative 2020 'Innovation Union' , whose objectives include defragmentation of research and educational capacities, tackling the major societal challenges (starting with healthy aging), and removing barriers to bringing ideas to the market.[11]

CONCLUSION
Permanent cooperation through ECRIN ERIC SMS is a position that enables younger doctors of Serbia the development of science teams in Europe and the world.Time will show whether we will succeed through ECRIN to apply medical knowledge of XXI century.Welcome to European science family.
And, most important parts of the development are human resources.As evidence of the results achieved in evidence based medicine are needed results published of course.Clearly, the objectives are: develop an infrastructure allowing for bottom-up harmonization of the support and training for, and practice of, clinical research; provide public sponsors for biotechnology small and medium-sized companies (SMEs) with support for translational research and multicentre clinical studies in Europe; publish papers in scientifi c-professional journals.Th e ECRIN SMS work was carried through TC every month, summer schools, questionnaires, meetings.Every year, ECRIN Director General Prof Jacques Mainard Demotes, ECRIN Capacity Director Christine Kubiak, European correspondents for Serbia (EUCOSs) Prim Dragana Maca Kastratovic and Dr Srdjan Djani Markovic, and ECRIN scientifi c programs representatives have presented the results of work on the Symposium.Clinical pharmacology week is traditionally held every year in the Serbian Medical Society organized by the Section for Clinical pharmacology.[3,4,5,6,7,8,9] Th ere are no results without the teamwork SMS, and thanks to the support of the President of the SMS, a member of the Serbian Academy of Arts and Sciences Professor Radoje Colovic; President SCPSMS, member of the Academy of Medical Sciences of Serbian Medical Society, Prof. Momir Mikov; SMS Manager Suzana Bjelogrlić, BSc; Vice manager of SMS Senka Miljenovic; people from fi nancial department SMS: Ruzica Petrovic and Snezana Milutinovic; the last but not the least -to all members of SCPSMS.As the very fi rst step ECRIN Director Prof Jacques Demotes elected ECRIN correspondents from countries which were interested to participate.ECRIN SMS correspondents are Doctors: Srdjan Markovic and Dragana Kastratovic, responsible for creation, development, communication, network in some countries.Th e plan for further development is very successful because it was administered by a team chosen from open minded doctors ready to learn and improve their knowledge.Th e result of years of work by ECRIN: permanent cooperation through ECRIN ERIC.ECRIN (European Clinical Research Infrastructure Network, www.ecrin.org)was offi cially awarded the status of European Research Infrastructure Consortium (ERIC), a legal status designed to facilitate the joint establishment and operation of research infrastructures of European interest.ECRIN-ERIC thus represents a major instrument for health innovation and for the optimization of healthcare strategies, fostering the competitiveness of European health industry, and promoting evidence-based medical practice for the benefi t of healthcare systems, of healthcare professionals, and of European patients and citizens [10].